Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Balding men had lower bone density, while balding women had higher hip bone density.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

In teens with Polycystic Ovary Syndrome and obesity, issues related to metabolism, skin, and mental health are common, and a clinic with various specialists can provide care for most of these problems.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Ashwagandha may improve hormone levels and reduce hair loss in non-classical adrenal hyperplasia.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

A patient with HAIR-AN syndrome, PCOS, and Hashimoto's thyroiditis improved with early diagnosis and treatment to prevent serious health problems.

No strong link between testosterone or DHEAS levels and acne or hair loss in females.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

COVID-19 can cause hair loss, but specialists can help treat it.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.